Mizuho Securities USA’s Edwards Lifesciences EW Stock Holding History

Mizuho Securities USA’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Sell	35,082 -7,172	-17%	-$591K	0.07%	317
2025 Q4	$3.66M	Sell	42,254 -507	-1%	-$41.6K	0.06%	278
2025 Q3	$3.48M	Buy	42,761 +2,216	+5%	+$173K	0.07%	276
2025 Q2	$3.17M	Sell	40,545 -6,680	-14%	-$498K	0.07%	283
2025 Q1	$3.42M	Sell	47,225 -8,675	-16%	-$621K	0.07%	275
2024 Q4	$4.14M	Buy	55,900 +16,838	+43%	+$1.18M	0.08%	253
2024 Q3	$2.58M	Sell	39,062 -7,396	-16%	-$537K	0.06%	297
2024 Q2	$4.29M	Buy	+46,458	New	+$4.11M	0.09%	202

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Mizuho Securities USA's EW Position: Q1 2026 in Review

Mizuho Securities USA reduced its Edwards Lifesciences (EW) stake by 17% in Q1 2026, selling an estimated $591K and leaving 35,082 shares worth $2.81M. The position accounts for 0.07% of the portfolio, ranked #317.

Mizuho Securities USA first reported a position in EW in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.29M in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Mizuho Securities USA held 35,082 shares of Edwards Lifesciences worth $2.81M as of Q1 2026.
Mizuho Securities USA sold 7,172 Edwards Lifesciences shares in Q1 2026, an estimated $591K.
Edwards Lifesciences made up 0.07% of Mizuho Securities USA's portfolio in Q1 2026, its #317 holding.
Mizuho Securities USA first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
Mizuho Securities USA's Edwards Lifesciences position peaked at $4.29M in Q2 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.